Standard Biotools (LAB) Total Debt Growth (1y) (2011 - 2024)
Standard Biotools (LAB) Total Debt Growth (1y) (2011 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 186.78 Bn | 179.48 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 131.95 Bn | 129.07 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 111.27 Bn | 102.05 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 68.58 Bn | 67.13 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 48.31 Bn | 44.63 Bn | 1.29 Bn | 0.12% |
| 6 | GE HealthCare Technologies | 29.23 Bn | 26.94 Bn | 1.98 Bn | -5.76% |
| 7 | Dexcom | 28.90 Bn | 27.78 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 28.19 Bn | 27.62 Bn | - | -2.49% |
| 9 | Koninklijke Philips | 24.33 Bn | 21.29 Bn | 2.01 Bn | 6.98% |
| 10 | Standard Biotools | 305.20 Mn | -149.97 Mn | 11.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 427.17% |
| Dec 31, 2023 | -18.13% |
| Sep 30, 2023 | -5.91% |
| Jun 30, 2023 | 2.26% |
| Mar 31, 2023 | 2.26% |
| Dec 31, 2022 | 2.27% |
| Sep 30, 2022 | 2.19% |
| Sep 30, 2012 | -83.82% |
| Jun 30, 2012 | -85.58% |
| Mar 31, 2012 | 126.54% |
| Dec 31, 2011 | -31.03% |